RETA-3 10MG Retatrutide Peptide

RETA-3 10MG is a research-focused retatrutide peptide product designed for laboratory and scientific research applications. Retatrutide, also known by the research designation LY3437943, is an investigational peptide that has been studied for its activity at three hormone receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors.

What Is Retatrutide?

Retatrutide is a synthetic peptide currently being investigated in clinical research. Unlike compounds that primarily target one receptor pathway, retatrutide has activity across GIP, GLP-1, and glucagon receptors, making it an important subject of metabolic and endocrinology research. Published research has examined retatrutide in adults with obesity, including its effects on body weight and related metabolic measures.

RETA-310MG for Research

RETA-3 10MG is intended for researchers studying retatrutide and related metabolic signaling pathways. Researchers may investigate the compound in controlled laboratory settings to better understand receptor activity, peptide behavior, metabolic signaling, and other areas of scientific interest.

A Phase 2 clinical study published in the New England Journal of Medicine investigated several retatrutide dose levels over 48 weeks in adults with obesity. The study evaluated body-weight changes, safety, and other clinical outcomes. These published findings provide a scientific basis for continued research into the properties and potential applications of retatrutide.

Research Characteristics

RETA-310MG can be incorporated into laboratory research involving peptide biology, receptor signaling, metabolic pathways, and related areas of scientific investigation. For researchers purchasing peptide materials, appropriate documentation, controlled handling, and consistent product identification are important considerations when conducting laboratory work.

Product specifications, including the stated quantity and any available analytical documentation, should be reviewed before use to ensure that the material is appropriate for the intended research protocol.

Quality-Focused Research Materials

At Peptira Peptides, our goal is to provide clearly identified research materials for laboratory use. Each product should be handled according to appropriate institutional procedures and applicable laboratory safety requirements.

Researchers should independently verify product specifications and analytical documentation before incorporating any research material into an experimental protocol.

Important Research-Use Notice

RETA-3 10MG is provided for research purposes only. It is not intended for human consumption, self-administration, diagnosis, treatment, prevention, or mitigation of any disease or medical condition. Retatrutide remains an investigational compound and is not approved for public use outside applicable clinical research settings.

RETA-31 0MG should be handled only by qualified personnel in an appropriate research environment and in accordance with applicable institutional safety procedures, regulations, and laboratory protocols.